Replies to post #224242 on Biotech Values

[caravon]

Too much money is floating around thanks to FED's ZIR policies.

It is another indication that money cannot buy everything. In science, talents & expertise are the real drivers.

PS
I did attend the latest ENTA's AM. They sounded confident in what they are doing.
It was also an interesting discussion regarding the ENTA future partnering approaches for its different pipeline candidates (assuming they are promising/successful). It would substantially cut the number of potential candidates.

[DewDiligence]

ENTA’s EASL lineup:

https://www.enanta.com/investors/news-releases/press-release/2019/Enanta-Pharmaceuticals-Announces-Data-Presentations-at-The-International-Liver-Congress-2019/default.aspx

[biocqr]

JNJ/Janssen RSV program...received a solicitation today to participate in this RSV vaccine P2 trial (5800 pts) which commenced Aug 1...

A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older

https://clinicaltrials.gov/ct2/show/NCT03982199